Poniard Pharmaceuticals Analysis
| PARDDelisted Stock | USD 0.01 0.00 0.00% |
Poniard Pharmaceuticals is overvalued with Real Value of 0.0085 and Hype Value of 0.01. The main objective of Poniard Pharmaceuticals pink sheet analysis is to determine its intrinsic value, which is an estimate of what Poniard Pharmaceuticals is worth, separate from its market price. There are two main types of Poniard Pharmaceuticals' stock analysis: fundamental analysis and technical analysis.
The Poniard Pharmaceuticals pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Poniard Pharmaceuticals' ongoing operational relationships across important fundamental and technical indicators.
Poniard |
Poniard Pink Sheet Analysis Notes
The company has price-to-book ratio of 0.1. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Poniard Pharmaceuticals recorded a loss per share of 3.79. The entity had not issued any dividends in recent years. The firm had 1:40 split on the 23rd of November 2011. Poniard Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of cancer therapeutics. Poniard Pharmaceuticals, Inc. was founded in 1984 and is based in Seattle, Washington. PONIARD PHARMACEUT operates under Biotechnology classification in the United States and is traded on PNK Exchange. It employs 7 people.The quote for Poniard Pharmaceuticals is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To find out more about Poniard Pharmaceuticals contact the company at 206 281 7001 or learn more at https://www.poniard.com/.Poniard Pharmaceuticals Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more pink sheets at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Poniard Pharmaceuticals' investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Poniard Pharmaceuticals or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| Poniard Pharmaceuticals is not yet fully synchronised with the market data | |
| Poniard Pharmaceuticals has some characteristics of a very speculative penny stock | |
| Poniard Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| Poniard Pharmaceuticals currently holds 1.57 M in liabilities with Debt to Equity (D/E) ratio of 0.53, which is about average as compared to similar companies. Poniard Pharmaceuticals has a current ratio of 0.74, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Poniard Pharmaceuticals until it has trouble settling it off, either with new capital or with free cash flow. So, Poniard Pharmaceuticals' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Poniard Pharmaceuticals sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Poniard to invest in growth at high rates of return. When we think about Poniard Pharmaceuticals' use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (30.05 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Poniard Pharmaceuticals currently holds about 1.98 M in cash with (24.28 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.32, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
Poniard Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 29. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Poniard Pharmaceuticals's market, we take the total number of its shares issued and multiply it by Poniard Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Poniard Pharmaceuticals Outstanding Bonds
Poniard Pharmaceuticals issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Poniard Pharmaceuticals uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Poniard bonds can be classified according to their maturity, which is the date when Poniard Pharmaceuticals has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Volcan Compania Minera Corp BondUSP98047AC08 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MPLX LP 4875 Corp BondUS55336VAG59 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| International Game Technology Corp BondUS460599AD57 | View |
About Poniard Pink Sheet Analysis
Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Poniard Pharmaceuticals prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Poniard shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Poniard Pharmaceuticals. By using and applying Poniard Pink Sheet analysis, traders can create a robust methodology for identifying Poniard entry and exit points for their positions.
Poniard Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of cancer therapeutics. Poniard Pharmaceuticals, Inc. was founded in 1984 and is based in Seattle, Washington. PONIARD PHARMACEUT operates under Biotechnology classification in the United States and is traded on PNK Exchange. It employs 7 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding Poniard Pharmaceuticals to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Sign In To Macroaxis Now
Sign In To MacroaxisSign in to explore Macroaxis' wealth optimization platform and fintech modules |
| All Next | Launch Module |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Consideration for investing in Poniard Pink Sheet
If you are still planning to invest in Poniard Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Poniard Pharmaceuticals' history and understand the potential risks before investing.
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Commodity Directory Find actively traded commodities issued by global exchanges |